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ABSTRACT
Objective." The purposes of this study were to compare the efficacy of amoxicillin and cephradine for the
treatment of sporadic acute puerperal mastitis (SAPM) and to evaluate the microbiology and clinical
parameters of this infection.
Methods: We conducted a prospective, randomized, single-blinded study comparing amoxicillin, 500 mg
orally q 8 h for 7 days, and cephradine, 500 mg orally q 6 h for 7 days. The diagnostic criteria for SAPM
included a temperature of >-37.56C (->99.6F) and erythema and tenderness of the breast(s).
Results: Twenty-seven consecutive outpatients with SAPM were evaluated for admission to the study,
and 25 of these were enrolled. The mean temperature at enrollment was 38.17C (100.7F), with a mean
WBC count of 11,440/txl. The most frequent bacterial isolates from expressed milk were Staphylococcus
aureus (7), staphylococcal species (coagulase negative) (8), and a-hemolytic streptococci (4). There were
no significant differences between the 2 antibiotic regimens in cure rate, mean days to resolution of
symptoms, or recurrence within 30 days. Both of the treatment failures and of the 3 recurrences within
30 days were amoxicillin-treated patients whose cultures grew S. aureus.
Conclusions: Oral amoxicillin and cephradine appear equally effective in the treatment ofSAPM. Staphylo-
cocci were the most frequent isolates from the milk of women with mastitis.
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poradic acute puerperal mastitis (SAPM) has
been a recognized complication of breast-feed-
ing since the process began. In 1953, Gibberd cate-
gorized puerperal infections of the breast as epi-
demic and nonepidemic (sporadic). Epidemic
mastitis is defined as acute adenitis and cellulitis
primarily involving the lactiferous apparatus of the
breast and often including nonadjacent lobes. It is
usually seen in hospital outbreaks with transmission
among mothers, babies, and hospital personnel.
Most cases are caused by virulent strains ofStaphylo-
coccus aureus. ’2 Nonepidemic mastitis is defined as
acute puerperal cellulitis with extension to the peri-
glandular connective tissue. This connective-tissue
infection results in a V-shaped area of involvement
among the lobes.
S. aureus, staphylococcal species (coagulase nega-
tive), group B streptococci, enterobacteriaceae, and
anaerobic bacteria have been isolated from the milk
of mothers with mastitis.3’4 There are also data that
potentially pathogenic bacteria may be isolated
from the milk of nursing mothers who are not clini-
cally infected,
Actually, mastitis is a clinical and pathologic term
that describes any inflammatory condition of the
breast. The most frequent of these conditions is
puerperal mastitis, an infection of the breast pro-
ducing localized tenderness, erythema, and heat
together with flu-like symptoms. Modern studies
have reported the incidence of SAPM to be 2.5-
2.9% of lactating mothers. 5’6 Although reviews and
descriptive articles about puerperal mastitis are nu-
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merotls,4’7-9 few well-designed, prospective trials
have focused on the epidemiologic aspects, eti-
ology, and treatment of SAPM. The antibiotics
studied have included [3-1actamase-susceptible
penicillins, penicillinase-resistant penicillins, ceph-
alosporins, erythromycin, trimethoprim/sulfameth-
oxazole, and metronidazole. 7,1,11 The purpose of this
study was to determine the clinical parameters, bac-
terial etiology, and response to antibiotic treatment
of a cohort of mothers with SAPM. Amoxicillin and
a cephalosporin were compared because these 2
antibiotics are most frequently prescribed to treat
mastitis by members of the Infectious Diseases So-
ciety for Obstetrics and Gynecology. lz
MATERIALS AND METHODS
In this prospective, randomized, single-blinded
study, a cohort of women with SAPM delivered
by a single physician (W.D.H.) was randomized to
treatment. The diagnostic criteria for SAPM were
an oral temperature of ->37.56C (>-99.6F) plus
tenderness to palpation of the breast and segmental
erythema. All 3 criteria were required for the diag-
nosis ofSAPM. The exclusion criteria included ma-
ternal age of< 18 years, documented allergy to peni-
cillins or cephalosporins, and antibiotic therapy
within the previous 30 days.
The candidates for the study were lactating
women who presented to the outpatient clinic with
complaints of fever and breast discomfort. Upon
examination, if the clinical criteria for diagnosis
were met and no exclusion criteria were noted, the
patient was offered participation in the study. If she
agreed, an informed consent was signed. Historical
information and study data were recorded on pre-
coded data sheets.
After the areola was prepped with betadine, a
specimen for cultures was obtained by expressing
milk from the involved breast(s). After 3-4 drops
were discharged, the milk was aspirated, placed
onto transport media (modified Stuart’s and modi-
fied Amies), and taken immediately to the labora-
tory for aerobic and anaerobic cultures, respectively.
A Gram’s stain was done on each isolate. The cul-
tures were reported as mild, moderate, or heavy
growth. A venous blood sample was also obtained
for a CBC and WBC differential.
The study patients were randomized to of 2
oral antibiotic regimens using presealed, opaque
envelopes. The investigators were blinded to the
antibiotic used. The treatment regimens were oral
amoxicillin, 500 mg q 8 h for 7 days, or oral cephrad-
ine, 500 mg q 6 h for 7 days. Each patient was asked
to continue breast-feeding and to apply warm, moist
compresses to the involved breast(s) q 4-6 h. She
was instructed to notify the physician if her temper-
ature remained >37.56C (>99.6F) after 48 h or if
she was unable to comply with the antibiotic
regimen.
The study patients were seen for follow-up visits
in 7 days. The symptoms and signs of disease were
recorded, and an assessment of immediate cure or
failure was made based on a resolution of the 3
principal diagnostic criteria: fever, erythema, and
tenderness. A repeat CBC was drawn, if the patient
had not responded to treatment, repeat cultures
were obtained. The women who responded to treat-
ment but subsequently developed findings of
SAPM within 30 days were considered recurrences.
A statistical analysis was carried out using the
Fisher’s exact test (2-tailed). The differences were
considered significant at P < 0.05.
RESULTS
From July 1, 1991, until December 31, 1993, 566
women were delivered. Of those, 380 (67.1%)
nursed their infants. Twenty-seven mothers (4.8%)
who breast-fed presented with clinical findings of
SAPM and 25 of them consented to participation
in the study. One patient declined enrollment in
the study and took antibiotics within the previous
2 weeks.
Thirteen patients were randomized to treatment
with amoxicillin and 12 to treatment with cephra-
dine. There were no significant differences be-
tween the 2 groups in days to onset of infection,
duration of symptoms before diagnosis, presence of
cracked nipples at the time of diagnosis, bilateral
involvement, mean temperature at diagnosis, or
mean WBC count at diagnosis (Table 1). There
were also no differences in mean age, parity, history
of mastitis, or history of diabetes mellitus.
All study patients met the entry criteria of a
temperature of ->37.56C (->99.6F) and erythema
and tenderness of the breast(s). The mean time
from delivery until the diagnosis ofSAPM was 55.4
days. The mothers presented for care an average
of 47.4 h after the symptoms began. Twenty (80%)
had edema of the breast(s) and 16 (64%) had
cracked nipples (10 in the amoxicillin group and 6
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TABLE I. Clinical parameters (means) of SAPM
Amoxicillin (N 13) Cephradine (N 12) Total
Days to onset
Duration (h) of symptoms
before diagnosis (range)
Nipple cracked
Bilateral involvement
Mean temperature (range)
Mean WBC count ( 109/I)
(range)
56.5
39.6 (I 2-72)
54.3 55.4 (4-259)
52.4 (12-168) 47.4 (12-168)
10 (77%) 6 (50%) 16 (64%)
(%)
38.7c 38. c 38.7
(37.56-39.72) (37.56-39.44) (37.56-39.72)
100.7F 100.6F 100.7F
(99.6-103.5) (99.6-103) (99.6-103.5)
11.9 10.9 11.4
(5.- 6.8) (6.8- 6. ) (7.- 6.8)
TABLE 2. Bacteriology (principal isolates) of SAPM
s. aureus (PCN-R, Ceph-S) 7
Amoxicillin-treated 3
Cephradine-treated 4
Staphylococcal species (PCN-R, Ceph-S) 8
Amoxicillin-treated 4
Cephradine-treated 4
a Streptococcus 4
Group B streptococcus 2
Propionibacterium acne
aPCN-R penicillin-resistant; Ceph-S cephradine-sensitive.
in the cephradine group). The mean temperature
at admission of all patients was 38.17C (100.7F)
and the mean WBC count was 11,440/txl.
The bacteria isolated from the milk of patients
are listed in Table 2. Staphylococci were the most
frequent isolates. All of the staphylococcal isolates
were resistant to penicillin and sensitive to cephalo-
sporins. The coagulase-negative staphylococci were
not speciated. Each of the positive cultures had
moderate or heavy growth of the principal isolate.
There were 2 treatment failures in the amoxicil-
lin group, 1 of whom developed a unilateral breast
abscess. This patient had no clinical evidence of an
abscess at the time of the initial diagnosis. One of
these treatment failures had cracked nipples (the
abscess patient) and the other did not. The cultures
of both treatment failures grew S. aureus from their
breast milk. The mother with the abscess was
treated with incision and drainage of the abscess
and a parenteral cephalosporin. A culture of the
abscess taken at the time of the procedure grew S.
aureus. The other treatment failure received oral
cephradine and responded readily. Her cultures also
grew S. aureus at the time of retreatment. There
were no failures in the cephradine group (Table 3).
There was recurrence within 30 days of treat-
ment in the amoxicillin group. This patient’s admis-
sion culture grew S. aureus and her culture at the
time of the recurrence grew the same organism.
There were 2 recurrences within 30 days in the
cephradine group, with both culturing coagulase-
negative staphylococcal species at admission to the
study. The cultures at the time of recurrence on
both of these patients were negative (Table 3).
One patient in each group had bilateral breast
involvement, including the patient with the unilat-
eral abscess. There were no adverse side effects
to the antibiotics administered. The women were
questioned about compliance with dosing at the
return visit, and all indicated that they had taken
their medication as prescribed.
DISCUSSION
SAPM is an infection of the breast that complicates
breast-feeding in 2.5-2.9% of women, according to
modern studies.5’6 Although 1 report indicated that
mastitis occurred at least once in approximately
one-third of mothers during a single lactation
course, this study was a retrospective analysis by
questionnaire depending on recall for data. In our
prospective analysis, the symptoms of SAPM
caused 4.8% of 380 nursing mothers to seek care.
Various clinical parameters have been evaluated
in other studie. 5’13’14 It has been found that 67% of
patients have the onset of symptoms in the first
6 months of nursing. The mean time to onset of
symptoms was reported to be 38 days. Both breasts
were involved 8-10% of the time. A recurrence of
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TABLE 3. Results of SAPM
Amoxicillin (N 13) Cephradine (N 12)
Treatment failures* 2 (S. aureus)
(15.4%)
Days to resolution of symptoms* (range) 4.2 (I-5)
Abscess*
Recurrences within 30 days* (S. aureus)
Bilateral involvement
0
o
2 (coagulase-negative staphylococcal species)
*P NS (Fisher’s exact test).
mastitis occurred within 30 days of the cessation of
treatment in 8-10% of patients. An abscess compli-
cated the acute process in 1-11% of nursing
mothers.
Thomsen et al. 15 demonstrated that the lactating
breast is susceptible to infection by inducing masti-
tis in lactating mice with the inoculation ofS. epider-
midis or S. saprophyticus into their mammary glands.
Other investigators have reported S. aureus to be
the principal isolate in 48-50% of cases.4’5 Other
isolates have included coagulase-negative staphylo-
coccal species, group B streptococci, Enterobacteri-
aceae, and anaerobic bacteria.
In our study of lactating mothers, S. aureus was
recovered from the milk of 3 amoxicillin-treated
women and 4 cephradine-treated women, for a total
isolation rate of28%. Staphylococcal species (coagu-
lase negative) were isolated from the milk of 4
amoxicillin-treated and 4 cephradine-treated moth-
ers, for a total isolation rate of 32%. These isolation
rates are consistent with those referenced above.
Since 60% of the mothers had staphylococci cul-
tured from their milk, it seems prudent to treat
women with SAPM with an antibiotic that is effec-
tive against these bacteria, if these bacteria truly
infect the breast parenchyma.
All of the staphylococcal isolates were resistant
to penicillin and sensitive to cephalosporins. Both
treatment failures occurred in the amoxicillin group,
and both patients’ cultures grew S. aureus upon
admission to the study and at the time of their
assessments as treatment failures. One of these
women developed a breast abscess; the other re-
sponded when her antibiotic was changed to
cephradine. The culture of the amoxicillin-treated
patient with a recurrence also grew staphylococcal
species (coagulase negative) and she responded to
treatment with cephradine.
Among the amoxicillin-treated group, whose
culture grew S. aureus and 4 whose cultures grew
staphylococcal species responded to treatment in
spite of the fact that the isolates were resistant in
vitro. This finding may emphasize the importance
of emptying the breast and using warm, moist com-
presses in the treatment of SAPM.
We recognize that the number of patients in this
study is small. In a post hoc analysis, if we assume
a 15% failure rate for amoxicillin and a 1% failure
rate for cephradine, with an ot of 0.05 and desired
power of 0.8, 72 patients would be required for each
arm of the study using a continuity correction for
small numbers. Based on our recruitment of nursing
mothers, a delivery population of 3,264 women
would be required. We will continue to recruit more
patients to achieve these numbers and will report
those data.
There was no statistically significant difference
in response to antibiotic treatment (P > 0.05) be-
tween the 2 regimens. The facts that both failures
were initially treated with amoxicillin (a [3-1acta-
mase-susceptible penicillin), the abscess was found
in an amoxicillin-treated patient, and all of the
staphylococcal isolates were penicillin-resistant
cause us to express our bias toward the recommen-
dation of a [3-1actamase-resistant antibiotic such as
a cephalosporin along with the application of moist
heat and continued breast-feeding.
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